Release 4 FHIR CI-Build

This page is part of the Continuous Integration Build of FHIR Specification (v4.0.1: R4 - Mixed Normative and STU ) in it's permanent home (it will always (will be available incorrect/inconsistent at this URL). The current version which supercedes this version is 5.0.0 . For a full list of available versions, see times).
See the Directory of published versions . Page versions: R5 R4B R4

Plandefinition-opioidcds-08

Example PlanDefinition/opioidcds-08 (Narrative)

Maturity Level : N/A
Responsible Owner: Clinical Decision Support Work Group Standards Status : Informative Compartments : Not linked to any No defined compartments

This is the narrative for the resource. See also the XML , JSON or Turtle format. This example conforms to the profile PlanDefinition .

Generated Narrative with Details Narrative: PlanDefinition opioidcds-08

id : opioidcds-08

url StructureDefinition Work Group : http://hl7.org/fhir/ig/opioid-cds/PlanDefinition/opioidcds-08 cds

identifier : cdc-opioid-guidance (OFFICIAL) Uniform Resource Identifier (URI) /urn:oid:2.16.840.1.113883.4.642.11.10, cdc-opioid-guidance (use: official, )

version : 0.1.0

name : cdc-opioid-08 Cdcopioid08

title : CDC Opioid Prescribing Guideline Recommendation #8

type : ECA Rule (Details : {http://terminology.hl7.org/CodeSystem/plan-definition-type code 'eca-rule' = 'ECA Rule', given as 'ECA Rule'})

status : draft Draft

date : 19/03/2018 2018-03-19

publisher : Centers for Disease Control and Prevention (CDC) HL7 International / Clinical Decision Support

contact : http://www.hl7.org/Special/committees/dss

description :

Clinicians should incorporate into the management plan strategies to mitigate risk, including considering offering naloxone when factors that increase risk for opioid overdose, such as history of overdose, history of substance use disorder, higher opioid dosages (≥50 MME/day), or concurrent benzodiazepine use, are present.

UseContexts

- useContext : , Code Value[x]
* UsageContextType: focus (Clinical Focus) Medication requested (situation)
* UsageContextType: focus (Clinical Focus) Chronic pain (finding)

jurisdiction : United States of America (Details : {urn:iso:std:iso:3166 code 'US' = 'United States of America', given as 'United States of America'})

purpose :

CDC’s Guideline for Prescribing Opioids for Chronic Pain is intended to improve communication between providers and patients about the risks and benefits of opioid therapy for chronic pain, improve the safety and effectiveness of pain treatment, and reduce the risks associated with long-term opioid therapy, including opioid use disorder and overdose. The Guideline is not intended for patients who are in active cancer treatment, palliative care, or end-of-life care.

usage :

Before starting and periodically during continuation of opioid therapy, clinicians should evaluate risk factors for opioid-related harms.

copyright :

© CDC 2016+.

topic : Opioid Prescribing (Details )

author : Kensaku Kawamoto, MD, PhD, MHS: , Bryn Rhodes: , Floyd Eisenberg, MD, MPH: , Robert McClure, MD, MPH:

relatedArtifact

type : , Documentation

display : CDC guideline for prescribing opioids for chronic pain

Documents

- Url
* https://guidelines.gov/summaries/summary/50153/cdc-guideline-for-prescribing-opioids-for-chronic-pain---united-states-2016#420

relatedArtifact

type : Documentation

display : MME Conversion Tables

Documents

- Url
* https://www.cdc.gov/drugoverdose/pdf/calculating_total_daily_dose-a.pdf

library : Library/opioidcds-recommendation-08 http://example.org/fhir/Library/opioidcds-recommendation-08

action

Strength of recommendation : Strong

Quality of evidence : Low quality

title : Existing patient exhibits risk factors for opioid-related harms.

description :

Checking if the trigger prescription meets the inclusion criteria for recommendation #8 workflow.

Documentations

- Type
* Documentation

Triggers

- Type Name
* Named Event medication-prescribe

documentation : condition

trigger kind : Applicability

Conditions Expressions

- Kind Description Language Expression
* applicability Check whether the existing patient exhibits risk factors for opioid-related harms, such as concurrent use with benzodiazepine, a history of substance abuse, and/or an average MME greater than 50 mg/day. text/cql-identifier Inclusion Criteria

groupingBehavior : visual-group Visual Group

selectionBehavior : exactly-one Exactly One

dynamicValue

path : action.description

Expressions

- expression : Language Expression
* text/cql-identifier Get Detail

dynamicValue

path : action.title

Expressions

- expression : Language Expression
* text/cql-identifier Get Summary

dynamicValue

path : action.extension

Expressions

- expression : Language Expression
* text/cql-identifier Get Indicator

Actions

- Description
*

Will offer Naloxone instead

*

Risk of overdose carefully considered and outweighed by benefit; snooze 3 mo

*

N/A - see comment; snooze 3 mo

 

 

Usage note: every effort has been made to ensure that the examples are correct and useful, but they are not a normative part of the specification.